Simcere Pharmaceutical Group Limited (HKG:2096)
Hong Kong · Delayed Price · Currency is HKD 10.96
-0.22 (-1.97%)
May 19, 2026, 1:15 PM HKT
HKG:2096 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 1,344 | 722 | 714.76 | 930.87 | 1,507 |
Depreciation & Amortization | 380.82 | 337.84 | 291.51 | 268.66 | 234.39 |
Other Amortization | 0.02 | 0.02 | 18.09 | 14.99 | 17.42 |
Loss (Gain) From Sale of Assets | -0.23 | 1.5 | -791.92 | 10.57 | -402.02 |
Asset Writedown & Restructuring Costs | - | - | 28.47 | - | - |
Loss (Gain) From Sale of Investments | -137.08 | 266.25 | 744.82 | -113.11 | -697.19 |
Loss (Gain) on Equity Investments | 1.11 | -2.16 | -7.84 | -0.19 | 44.19 |
Stock-Based Compensation | 89.57 | 97.81 | 12.12 | 138.29 | 62.39 |
Provision & Write-off of Bad Debts | -2.92 | -6.84 | -0.87 | -13.97 | 15.83 |
Other Operating Activities | -103.69 | 48.9 | 62.68 | 38.36 | -182.36 |
Change in Accounts Receivable | -192.72 | -95.46 | -322.9 | 86.24 | -545.2 |
Change in Inventory | -42.69 | -24.53 | -376.64 | -116.99 | -8.33 |
Change in Accounts Payable | - | - | - | - | 81.87 |
Change in Unearned Revenue | 72.38 | 5.57 | -10.24 | -14.26 | -30.34 |
Change in Other Net Operating Assets | 604.97 | 40.24 | -210.99 | 124.65 | -299.73 |
Operating Cash Flow | 2,014 | 1,391 | 151.05 | 1,354 | -201.97 |
Operating Cash Flow Growth | 44.74% | 820.99% | -88.84% | - | - |
Capital Expenditures | -349.33 | -369.98 | -483.18 | -342.82 | -209.49 |
Sale of Property, Plant & Equipment | 0.76 | 50.09 | 118.31 | 0.27 | 5.91 |
Divestitures | - | 34.11 | 993.52 | - | 97.7 |
Sale (Purchase) of Intangibles | -512.88 | -405.6 | -496.67 | -335.19 | - |
Investment in Securities | -530.68 | -512.98 | 793.29 | 479.5 | -1,091 |
Other Investing Activities | 61.45 | 131.65 | 162.54 | 266.54 | 761.71 |
Investing Cash Flow | -1,331 | -1,073 | 1,088 | 68.31 | -435.5 |
Long-Term Debt Issued | 1,052 | 1,253 | 1,216 | 916.93 | 1,027 |
Total Debt Issued | 1,052 | 1,253 | 1,216 | 916.93 | 1,027 |
Long-Term Debt Repaid | -1,132 | -1,505 | -1,367 | -1,233 | -2,505 |
Total Debt Repaid | -1,132 | -1,505 | -1,367 | -1,233 | -2,505 |
Net Debt Issued (Repaid) | -80.09 | -252.13 | -151.07 | -316.38 | -1,478 |
Issuance of Common Stock | 1,427 | 30.84 | - | - | - |
Repurchase of Common Stock | -74.3 | -687.99 | -289.07 | - | - |
Common Dividends Paid | -390.75 | -401.48 | -419.22 | -391.3 | -391.3 |
Other Financing Activities | 12.45 | 934.19 | -35.47 | -46.01 | 244.75 |
Financing Cash Flow | 894.39 | -376.56 | -894.83 | -753.68 | -1,625 |
Foreign Exchange Rate Adjustments | -17.74 | 2.29 | 4.83 | 15.12 | -35.1 |
Net Cash Flow | 1,560 | -55.85 | 348.85 | 683.85 | -2,297 |
Free Cash Flow | 1,664 | 1,021 | -332.13 | 1,011 | -411.46 |
Free Cash Flow Growth | 62.97% | - | - | - | - |
Free Cash Flow Margin | 21.52% | 15.39% | -5.03% | 15.99% | -8.23% |
Free Cash Flow Per Share | 0.67 | 0.41 | -0.13 | 0.39 | -0.16 |
Cash Interest Paid | 21.26 | 30.79 | 35.47 | 29.98 | 70.85 |
Cash Income Tax Paid | 341.06 | 114.54 | 10.18 | -7.1 | 14.7 |
Levered Free Cash Flow | 776.72 | 429.35 | -1,045 | 175.48 | 438.89 |
Unlevered Free Cash Flow | 836.6 | 472.83 | -1,023 | 196.99 | 483.17 |
Change in Working Capital | 441.94 | -74.18 | -920.76 | 79.64 | -801.72 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.